Top Story

Higher CV risk with acarbose than metformin in type 2 diabetes

March 27, 2015
In patients with type 2 diabetes, an initial regimen of acarbose therapy was associated with a moderately higher risk for cardiovascular disease compared with metformin therapy, according to recent findings.

In the nationwide cohort study, Lee-Ming Chuang, MD, PhD, of Nationwide Taiwan University Hospital, and colleagues evaluated data from the Taiwan National Health Insurance Database. The database includes information on outpatient visits, hospital admissions, prescriptions, disease and deaths for 99% of the population of Taiwan.

In the Journals

Updated diabetes care guidelines for PCPs stress importance of individualized treatment

March 23, 2015
Recent updates to the American Diabetes Association’s Standards of Medical Care in Diabetes place an emphasis on individualizing and tailoring care to each…
In the Journals

Diabetes prevalence lower in patients with familial hypercholesterolemia than unaffected relatives

March 11, 2015
Patients with familial hypercholesterolemia had a lower prevalence of type 2 diabetes compared with relatives without familial hypercholesterolemia, according to a…
Gabriela Vazquez-Benitez In the Journals

Diabetes, CVD increase rates of CV events

February 27, 2015
Among adults with diabetes, paying extra attention to traditional cardiovascular risk factors could reduce the rates of cardiovascular events and mortality, according to…
CME
Best of Lipid Forum III

Best of Lipid Forum III

This activity is supported by an educational grant from Amgen, Inc.

Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and…
More »
In the Journals

CABG, newer-generation DES yielded similar mortality rates in patients with diabetes

June 26, 2014
Comparable mortality rates were reported for patients with diabetes treated with CABG or PCI using a cobalt-chromium everolimus-eluting…
FDA News

FDA: No clear link between olmesartan, CV risk among patients with diabetes

June 24, 2014
The FDA today announced that a safety review of olmesartan indicates no increased risk for CV events among patients with diabetes.According to a…
Meeting News CoveragePerspective

Empagliflozin reduced BP for patients with type 2 diabetes, hypertension

June 23, 2014
CHICAGO — In patients with type 2 diabetes and hypertension, empagliflozin significantly reduced BP in addition to improving blood glucose…
Meeting News Coverage

More than 10% of patients with acute MI may have undiagnosed diabetes

June 16, 2014
It is estimated that about 10% of patients with MI may also have undiagnosed diabetes, according to new research presented at the American Heart…
Meeting News Coverage

OGTT after MI reveals high undiagnosed diabetes, subsequent high mortality

June 14, 2014
SAN FRANCISCO — New research looking at oral glucose tolerance testing 4 days after both ST-elevation myocardial infarction and non-ST-elevated…
Meeting News CoveragePerspective

Experts debate ACC/AHA lipid guidelines

June 13, 2014
SAN FRANCISCO — Two researchers argued whether or not the recently issued American College of Cardiology and American Heart Association…

Groups launch clinical registry to track, improve quality of diabetes and cardiometabolic care

June 11, 2014
The American College of Cardiology, in collaboration with the American Diabetes Association, American College of Physicians and Joslin Diabetes…
In the Journals

Diabetes yielded negative clinical, economic outcomes after CABG

June 9, 2014
Patients in China with diabetes who were undergoing CABG incurred higher costs and had poorer long-term results than patients without diabetes…
Meeting News Coverage

Weight loss at any age can result in long-term CV benefit

May 22, 2014
A decrease in BMI category at any age in adulthood was associated with improvement in CV risk factors, even if the weight loss was not sustained…
Meeting News CoverageVideo

Video: Shared factors of cardiovascular risk and metabolic health in women

May 22, 2014
Endocrine Today caught up with Yehuda Handelsman, MD, FACP, FACE, FNLA, president-elect of the American College of Endocrinology, at AACE’s…
More Headlines »
morganatic-roan
morganatic-roan